- Year 2016
- Sant Joan Despí Moisès Broggi Hospital
Superiority study, phase III, multicenter, randomised, double blind, double simulation, with active comparator and directed by events, which compares rivaroxaban 15 mg once daily with aspirin 100 mg, in the secondary prevention of cerebrovascular accident and systemic embolism in patients who have recently suffered an embolic cerebrovascular accident of undetermined etiology (ACEI). (NAVIGATE ESUS)